Zika, Ebola, and the Future of Other Public Health Diseases Discussed at Fortune Brainstorm Health Live Tomorrow

Join public health experts from GSK, Time, and the Center for Infectious Disease Research and Policy at the University of Minnesota as they discuss the future of tracking emerging diseases

SOURCE: GSK

DESCRIPTION:

Just a few months after the 2015 outbreak of Ebola was contained, another virus—called Zika—commanded the public stage. It took but 14 months after Zika’s first detection in Brazil for the virus to spread through Latin America and the Caribbean to Florida. So far, the threat has gone unchecked. And to be sure, after Zika, will come another global pathogenic threat—one, that public health experts worry, may do an even better job of outsmarting and overwhelming us. The question is whether technological advances can help us turn the odds. Can big data and genomic virus sequencing help us track emerging diseases, contain their spread and ultimately find antidotes for the next unknown pathology? Can it speed up the hunt for lifesaving vaccinations or drugs? The answers have an urgency like few others.

Follow along live here at 7:30 EST/4:30 PST on November 1st

Tweet me: Join public health experts from #GSK @TimeHealth and @UMNewsas they discuss the future of tracking emerging diseases http://bit.ly/2faObmJ

KEYWORDS: Health, Events, Conferences & Webinars, GSK, GlaxoSmithKline, public health, Zika, ebola, Fortune Brainstorm Health, Moncef Slaoui

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.